Koninklijke Philips (RYLPF) FCF Payout Ratio Growth (3y) (2012 - 2025)

Koninklijke Philips (RYLPF) FCF Payout Ratio Growth (3y) (2012 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Cover Growth (3y) (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 0.91%
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -3.43%
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -18.36%
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn -
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn -
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -
10 Koninklijke Philips - - 2.07 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2025 49.35%
Dec 31, 2024 89.40%
Dec 31, 2023 -29.42%
Dec 31, 2022 -74.05%
Jun 30, 2022 53.31%
Dec 31, 2021 -33.32%
Jun 30, 2021 12.10%
Dec 31, 2020 -26.04%
Dec 31, 2019 -518.60%
Sep 30, 2019 -63.10%
Jun 30, 2019 -172.79%
Dec 31, 2018 -1.06%
Jun 30, 2018 -23.59%
Dec 31, 2017 51.39%
Jun 30, 2016 61.79%
Dec 31, 2015 30.03%
Sep 30, 2015 -40.24%
Jun 30, 2015 -19.56%
Dec 31, 2014 37.16%
Jun 30, 2013 -18.08%